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Intracranial aneurysms are increasingly being treated with endovascular therapy, namely
coil embolization. Despite being minimally invasive, partial occlusion and recurrence
are more frequent compared to open surgical clipping. Therefore, an alternative
treatment is needed, ideally combining minimal invasiveness and long-term efficiency.
Herein, we propose such an alternative treatment based on an injectable, radiopaque
and photopolymerizable polyethylene glycol dimethacrylate hydrogel. The rheological
measurements demonstrated a viscosity of 4.86 ± 1.70 mPa.s, which was significantly
lower than contrast agent currently used in endovascular treatment (p = 0.42),
allowing the hydrogel to be injected through 430 µm inner diameter microcatheters.
Photorheology revealed fast hydrogel solidification in 8 min due to the use of a new
visible photoinitiator. The addition of an iodinated contrast agent in the precursor
contributed to the visibility of the precursor injection under fluoroscopy. Using a
customized light-conducting microcatheter and illumination module, the hydrogel was
implanted in an in vitro silicone aneurysm model. Specifically, in situ fast and controllable
injection and photopolymerization of the developed hydrogel is shown to be feasible
in this work. Finally, the precursor and the polymerized hydrogel exhibit no toxicity
for the endothelial cells. Photopolymerizable hydrogels are expected to be promising
candidates for future intracranial aneurysm treatments.
Keywords: intracranial aneurysms (IA), injectable hydrogels, in situ photopolymerization, light-conducting
microcatheter, polyethylene glycol dimethacrylate
INTRODUCTION
Intracranial aneurysms (IAs) are saccular dilatations or outpouchings of brain arteries that are
prone to rupture, causing death or severe morbidity in over half of the patients (Medical Advisory
Secretariat, 2006). While minimally invasive endovascular therapy has many advantages and is
increasingly being performed, the risk of IA recurrence remains higher compared to surgical
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clipping (Molyneux et al., 2015; Smith et al., 2015; Hulsbergen
et al., 2019). Adjunctive devices such as flow diverting stents may
decrease this risk by promoting endothelial growth at the neck of
the IA (Ravindran et al., 2019) but currently require dual anti-
platelet medication to avoid parent artery thrombosis, thereby
increasing the risk of bleeding. Device compaction (Abdihalim
et al., 2014), inflammation (Tulamo et al., 2010) and intra-
saccular clot remodeling (Marbacher et al., 2019) appear to play
a decisive role in healing and recurrence. Therefore, a liquid
agent capable of (i) selectively filling the entire aneurysm, (ii)
reversing the chronic inflammatory wall changes, (iii) preventing
thrombosis, and (iv) attracting endothelial cells could eliminate
the current drawbacks of endovascular therapy.
Using liquid embolic agents to treat aneurysms is not a
new concept (Brassel and Meila, 2015). They allow the whole
volume of aneurysms of any shape or size to be filled. The
main limitation lies in their self-solidifying properties once in
contact with blood, risk of spillage and downstream migration
that may cause arterial occlusion and ischemic stroke. The risk
of microcatheter entrapment within the solid agent, particularly
with fast polymerizing substances such as acrylic glues, is also
significant (Walcott et al., 2011). While non-adhesive ethyl-
vinyl-alcohol (EVOH) copolymer agents precipitate over several
minutes (Kilani et al., 2015), the dimethyl sulfoxide (DMSO)
solvent they contain can induce vasospasm and angionecrosis
depending on the concentration and volume injected (Takeda
et al., 2015; Onyx R© Liquid Embolic System) which is especially
harmful if left to stagnate in such a restricted space as an
aneurysm. Moreover, leakage and solidification in the parent
artery remains a serious potential complication, even with
balloon assistance.
Injectable in situ forming hydrogels have raised considerable
interest for biomedical applications (Dimatteo et al., 2018; Li
et al., 2018; Zhang et al., 2019), including as potential novel
embolic agents for aneurysms or transcatheter embolization. The
liquid precursors of these hydrogel-based embolic agents have
been triggered to solidify in situ by different stimuli, such as
temperature (Takao et al., 2006; Zhao et al., 2013; Shi et al.,
2016), pH (Nguyen et al., 2016), chemical reaction (Bearat
et al., 2013; Weng et al., 2013; Zhou et al., 2016) or light
irradiation (Barnett et al., 2009; Ishikawa et al., 2012). Compared
to the others stimuli, light-induced photopolymerization allows
better spatial and temporal control of the curing (Doran et al.,
2015; Corrigan et al., 2019). This control is essential to avoid
any premature gelation or later dilution that could occur with
temperature-sensitive, pH-sensitive and chemically crosslinked
types. To our knowledge, only a few studies have developed
photopolymerizable hydrogels for IA treatment. Ishikawa et al.
(2012) have reported ex situ photopolymerization of hydrogels
in an aneurysm model whereas Barnett et al. (2009) described
in situ photopolymerization of hydrogels in a saccular aneurysm
model using 2.8 French-microcatheter (700 µm inner diameter).
To demonstrate the feasibility of in vitro implementation
of photopolymerizable hydrogels, many requirements need to
be taken into consideration. First, the hydrogel needs to be
biocompatible and safe to be injected in its liquid state in
the neuro- and cardiovascular systems, as a fraction of the
precursor is bound to leak into the blood flow, even under
balloon assistance. Second, it has to exhibit low viscosity to be
injectable through a microcatheter with an inner diameter of
430 µm, such as those used for coil delivery in current clinical
practice. Moreover, the hydrogel needs to be radiopaque to be
visible under fluoroscopy. Furthermore, despite evidence that a
balloon can remain inflated and block the flow in the parent
artery for as long as 18 consecutive minutes (Spiotta et al., 2011),
photopolymerization time should remain as short as possible,
10 min at most, ideally a few seconds, to diminish the risk
of ischemic stroke and vessel injury. Finally, use of light in
the visible spectrum to induce photopolymerization should be
preferred over ultraviolet emission to avoid possible damage to
encapsulated cells, host tissues or DNA (Sinha and Häder, 2002;
Fedorovich et al., 2009) and allow deeper light penetration within
a highly absorbing medium such as blood.
Photopolymerizable polyethylene glycol dimethacrylate
(PEGDMA) hydrogels have been widely used for tissue
engineering (Burke et al., 2019). Indeed, PEGDMA hydrogels
present many advantages such as tunable mechanical properties,
ease of chemical conjugation and biocompatibility. Herein, we
describe the use of a radiopaque photopolymerizable hydrogel
obtained from PEGDMA mixed with clinically approved
iodinated contrast medium and a next-generation visible
light-sensitive and water-soluble photoinitiator, known as
poly(ethylene glycol) substituted bis(acyl)phosphane oxides
(PEG-BAPO) (Wang J. et al., 2018). To address the challenge of
inserting a photoactivable hydrogel into an IA, we also present
the development of a light-conducting microcatheter (inner
lumen of 430 µm) combined with an illumination module
to guide visible light to the aneurysm. We hereby report a
proof-of-concept study to treat IAs with photopolymerizable
hydrogels under fluoroscopy in a realistic flow model (Figure 1),




All the chemicals were purchased from Sigma Aldrich (Merck,
Switzerland). The reactions were performed under inert
atmosphere of dry Argon using Schlenk techniques. Dry
solvents were drawn from a commercial solvent drying system
(Innovative Technology PURESOLV). The reaction flasks were
dried in an oven overnight at 120◦C before use. PEGDMA 6 kDa
was prepared from poly(ethylene glycol) (PEG,Mn = 6000 g/mol)
using a modified procedure from the previously reported one
(Lin-Gibson et al., 2004), as shown in Figure 2A. The polymer
(50 g) was loaded in a three necked 500 ml round bottomed
flask equipped with an adapter for the Schlenk line and a
Dean Stark condenser. The polymer was dissolved in 200 ml
of toluene. The mixture was stirred at 600 rpm and warmed to
160◦C. The mixture was refluxed for 1 h and every 15 min an
aliquot of 25 ml of solvent was removed using the Dean-Stark
condenser. After 100 ml of solvent were removed, the mixture
was cooled down to room temperature. Dry dichloromethane
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FIGURE 1 | Schematic illustration of the different steps of the new treatment concept. (A) Positioning of the light-conducting microcatheter in the aneurysm and
inflation of the balloon at the neck; (B) Rinsing of the aneurysm with contrast agent; (C) Injection of the hydrogel precursor; (D) 405 nm illumination and
photopolymerization of the hydrogel; (E) Removal of the microcatheter and balloon.
FIGURE 2 | (A) Synthesis of PEGDMA polymer. (B) Synthesis of PEG-BAPO photoinitiator.
(100 ml) was added to the mixture followed by Et3N (distilled
from CaCl2, stored in a Schlenk under Argon, 1.1 eq. for every
OH) and methacrylic anhydride (distilled from CaCl2, stored
in a Schlenk under Argon, 1.5 eq. for every OH). The mixture
was protected from light and stirred at room temperature
for 5 days. Subsequently, it was purified by filtration over a
neutral alumina plug. The polymer was coagulated into diethyl
ether and dried under high vacuum. The white powder was
obtained in quantitative yield and characterized as the desired
product via 1H-NMR. The degree of functionalization was
evaluated by integration of the 1H-NMR resonances. The
chemical structure of PEGDMA was confirmed using infrared
spectroscopy (FT-IR, Bruker Tensor 27, Germany) in the
infrared radiation range of 4000-400 cm−1 with a resolution of
4 cm−1 and 256 scans.
The iodine-based contrast medium Accupaque (350 mg/ml,
GE Healthcare, Chicago, IL, United States) was provided
by the Bern University Hospital. Intralipid 20%, an
intravenous fat emulsion, was purchased from Sigma Aldrich
(Merck, Switzerland).
The PEG-BAPO photoinitiator (PI) was synthetized by
phospha-Michael addition of bis(mesitoyl)phosphane (BAP-H)
to poly(ethylene glycol) methyl ether methacrylate (PEGMEM)
followed by oxidation with aqueous H2O2, as previously reported
(Wang J. et al., 2018). The synthesis of PEG-BAPO is shown in
Figure 2B.
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Hydrogel Precursor Preparation
The hydrogel precursor was prepared by dissolving PEGDMA
(10 wt%) in equivalent weight concentrations of phosphate
buffered saline (PBS) and Accupaque350. Since PEG-BAPO
PI was shown to be more efficient (higher curing rate) than
other commercially available water-soluble photoinitiators like
Irgacure2959 (Wang J. et al., 2018), we decided to add this (0.1
wt%) to the formulation. This hydrogel precursor formulation
was homogenized by Vortex for 5 min, degassed using a
vacuum pump and then passed through a 0.22 µm syringe-
filter (Rotilabo, Carl Roth, GmbH) for sterilization. Finally,
intralipids (5 wt%) were added to the hydrogel precursor to
enhance light-scattering and increase the polymerized volume
during subsequent illumination (Schmocker et al., 2014).
Injectability of the Hydrogel Precursor
The rheological properties of the hydrogel precursor were
assessed with a modular compact rheometer 102 (Anton Paar,
Peseux, Switzerland) by an oscillatory time sweep with a strain
oscillation of 5% at a frequency of 1 Hz applied during 5 min.
The dynamic viscosity was calculated as the average of the real
part of the complex viscosity. The viscosity of the precursor
was then compared with two reference samples, namely water
and Accupaque350.
Radiopacity of Precursor and Hydrogels
Using pulsed fluoroscopy (7.5-10 p/s) and serial angiography
snapshots (70 kV, 23 mA) on a HDR flat detector monoplane
system (154 µm pixel size, 16-bit digitization depth, Siemens
Artis Zee, Erlangen, Germany), the radiopacity of 2 mm-thick
samples of liquid precursor was assessed and compared to
an equal volume of solid hydrogel at t0 (immediately after
polymerization) and after incubation in PBS for 36 h. The results
were compared to pure Accupaque350 and to a single lumen
occlusion balloon (Scopernic15, Balt, Montmorency, France)
containing two radiopaque markers.
Photopolymerization
For photorheology, the light from a 405 nm wavelength light
laser diode was coupled to the modular compact rheometer 102
and a parallel 25 mm diameter disk configuration was used.
200µl samples of the hydrogel precursor were tested directly after
hydrogel preparation. A strain oscillation of 5% at a frequency of
10 Hz was applied and the temperature fixed at 37◦C. Samples
of 300 µm thickness were illuminated with a light intensity of
15 mW/cm2 at 405 nm. The evolution of the storage modulus
G′ was recorded during 405 nm irradiation. The polymerization
was considered complete when G′ reached a plateau level. The
time required to reach 95% of the plateau level of G′ was
defined as polymerization time, noted t95, as previously reported
(Khoushabi et al., 2015).
In vitro Aneurysm Model
The feasibility of hydrogel injection, photopolymerization
and implantation was evaluated in an in vitro aneurysm
model shown in Figure 3. Since approximately 30% of
IAs develop on the internal carotid artery, where flow
rate and turbulence in the aneurysm are higher compared
to more frequent aneurysm locations such as the anterior
communicating or middle cerebral artery (Bonneville et al.,
2006), we decided to model a paraophthalmic IA to simulate
the worst hemodynamic conditions. The setup consisted of a
wide necked, 5 × 6 mm left carotid ophthalmic aneurysm made
of soft silicone (Elastrat, Geneva, Switzerland), connected to
a peristaltic pump (Masterflex 7523-37, ColeParmer, Vernon
Hills, IL, United States) and head pump (Masterflex 7036-30,
ColeParmer, Vernon Hills, IL, United States) using 9.7 mm
inner diameter silicone tubing (Masterflex 96410-36, ColeParmer,
Vernon Hills, IL, United States). The pump parameters were
set to 1 Hz and 220 ml/min to mimic human internal carotid
artery flow rate (Enzmann et al., 1994). Additionally, a vertical
1.2 m liquid column inducing a constant pressure of 12 kPa
(90 mmHg) to mimic intracranial arterial pressure conditions
(91.2 ± 9.6 mmHg) (Netlyukh et al., 2015) was implemented.
The system was filled with a blood substitute composed of 36
vol% glycerol in water and PicroSirius Red dye (0.134 wt%) to
match blood viscosity (Lim et al., 2001) and light absorbance,
respectively. The dye concentration was determined using the
Beer-Lambert law (Supplementary Figure S1).
In vitro Proof-of-Concept of the
Implementation
In order to bring light to the aneurysm to photopolymerize the
hydrogel precursor in situ, two optical glass fibers (105 µm,
0.22 NA, 1.5 m, ThorLabs, Newton, NJ, United States) were
wrapped with heat shrunk hydrophilic tube (Vesta, Lubrizol
Company, Corona, CA, United States) along the outer surface
of a microcatheter typically used for IA coiling (Headway
17, MicroVention, Tustin, CA, United States). The tip of the
optical fibers was fixed to match the distal marker of the
microcatheter and connected proximally to an illumination
module composed of 405 nm, 200 mW light power laser diodes
(Fibotec Fiberoptics GmbH, Meiningen, Germany), as shown in
Figure 4. First, a 9F introducer sheath (Radifocus Introducer II,
Terumo, Tokyo, Japan) and 8F guide catheter (Mach1, Boston
Scientific, Marlborough, MA, United States) were inserted
in the input tubing. Under fluoroscopic guidance, the light-
conducting microcatheter was placed in the aneurysm sac
followed by the placement of an inflatable balloon (Scopernic15,
Balt, Montmorency, France) at the neck of the aneurysm. The
balloon was inflated, with a solution of Accupaque350 for
radiopacity and black ink to prevent light from polymerizing
leaked material in the parent artery. The blood substitute was
flushed out from the aneurysm cavity with a contrast agent
injected through the microcatheter under submaximal balloon
inflation, in order to minimize light absorption caused by red
dye and therefore maximize photopolymerization efficiency.
The hydrogel precursor was injected under blank roadmap
fluoroscopy using a dedicated 3 ml syringe wrapped in
aluminum foil (to avoid premature polymerization caused
by ambient light) until the contents of the aneurysm were
completely replaced and started to leak out downstream. After
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sealing the neck with maximal balloon inflation, the precursor
was illuminated by the optical fibers for 8 min. Following
photopolymerization, the microcatheter was removed under
balloon inflation to avoid fragmentation followed by progressive
balloon deflation and removal.
Cell Viability Assay
The cytotoxicity of the precursor was investigated by cell viability
assay. Human umbilical vein endothelial cells (HUVEC) were
cultured on a 96-well plate with 10,000 cells/well and 100 µl
of culture medium in each well. HUVEC were incubated for
48 h and evaluated for cell attachment and confluence. The
culture medium was aspirated and 100 µl of different conditions
of precursors were placed in contact with cells during 1 week.
Constant concentrations of 0.1, 0.5, 1, 2.5, 5, and 10 vol% were
tested. Three rounds of serial dilutions of the precursor were
also performed. For each of the dilution rounds, pure precursor
was placed in contact with HUVEC for 10 min, aiming to
simulate the contact of HUVEC with the precursor during the
injection and photopolymerization, 10 min being the maximum
polymerization time required for aneurysm application. Then,
the precursor was diluted at three different speeds, as shown
in Supplementary Figure S2, corresponding to the potential
dilution of the precursor into the blood stream during leakage in
the parent artery. To evaluate the cell viability after several time
points (24 h, 72 h, and 168 h), the mediumwas aspirated and each
well was filled with 100 µl of PBS with 10 vol% PrestoBlue assay
(A13261, Life Technologies). The culture medium was replaced
every 3 days. The fluorescence at 595 nm was measured by
a microplate reader (Wallac 1420 Victor2, PerkinElmer) after
30 min of incubation. Wells without precursor were considered
as positive controls.
To examine the possible toxicity of the solid, polymerized
hydrogels, HUVEC were cultured on a 48-well plate with 100,000
cells/well and 1 ml of culture medium in each well. The cells
were incubated during 24 h for cell attachment and confluence.
Cell strainers (70 µm pluriStrainers, pluriSelect) were laid on
the top of the wells and hydrogel samples were placed in the
strainers. Since unreacted particles, mainly the photoinitiator, can
be released into the blood stream during hydrogel immersion
and have a negative impact on cell viability, we assessed their
impact with a PrestoBlue assay immediately after polymerization
and after 1 day of incubation in PBS. The culture medium was
replaced every 3 days.
Platelet Aggregation Assay
Platelet aggregation, for different concentrations of precursor
ranging from 0.1 to 10 vol%, was determined as previously
described (Lima et al., 2019). Briefly, healthy human blood
samples were centrifuged for 15 min, 200 g at room temperature
(RT) and platelet-rich plasma (PRP) was collected. Blood samples
were centrifuged again for 15 min, 500 g at RT and platelet-
poor plasma (PPP) was collected. Twenty µl of different
concentrations of precursor were placed in a 384-well plate
(Greiner Bio One, ref 781903) and 20 µl of PRP was added
in each well. The absorbance at 595 nm was measured after
15 min incubation, 1200 RPM at RT and platelet aggregation
was determined by normalization with Tyrode buffer (0%
aggregation) and PPP (100% aggregation). Collagen I (Mölab, ref
0203009) at 5 µg/ml was also used as positive control.
Statistical Analysis
Each experiment was performed in triplicate or more and each
statistical evaluation was done with MATLAB (Mathworks,
Natick, MA, United States). All data are expressed as
mean ± standard deviation. One-way analysis of variance
(ANOVA) was used for comparison. P < 0.05 was considered as
a significant result (denoted as ∗) and p > 0.05 non-significant
(denoted ns). P < 0.01 was denoted as ∗∗ and p < 0.001 as ∗∗∗.
RESULTS
Characterization of PEGDMA Polymer
The degree of functionalization of PEGDMA was found by 1H-
NMR integrals to be over 90%. The functionalization of the PEG
with methyl methacrylate ending units was confirmed by the FT-
IR spectra, shown in Figure 5, recorded on the purified product.
The signal arising from the C = O stretching methyl methacrylate
substituent was visible at 1715.85 cm−1. A peak at 841.20 cm−1
was also observed, corresponding to the C = C bending. Thus,
the methacrylation functionalization of the PEG polymer was
confirmed by FT-IR.
Injectability of Hydrogels Precursors
The dynamic viscosity at room temperature (23◦C) of the
precursor and the contrast agent Accupaque350 were 6.53 ± 2.77
and 18.30 ± 4.85 mPa.s, respectively (Figure 6A). The water
viscosity of 1 mPa.s from literature was used as reference.
Comparatively, precursor viscosity was significantly lower than
Accupaque350 value (p = 0.022) and significantly higher than
water (p = 0.026). In addition, viscosities of other liquid
embolic agents, such as Onyx or PHIL, currently used in
endovascular therapy, range from 16 to 72 mPa.s (Vollherbst
et al., 2017). Therefore, our precursor should be injectable
through microcatheters.
Radiopacity of Hydrogels Precursors
The 2 mm-thick samples observed under fluoroscopy are
shown in Figure 6B. The radiopacity was compared with pure
Accupaque350 and the two radiopaque markers of a single lumen
occlusion balloon. The precursor and polymerized hydrogel were
clearly visible under fluoroscopy, although less radiopaque than
pure contrast agent. As expected, the iodinated content of the
hydrogel was no longer visible after 36 h of incubation in PBS.
Photopolymerization of Hydrogels
Photorheology measurements showed that the hydrogel
precursor completely polymerized after 8 min 15 s ± 1 min
36 s under a 405 nm illumination at 15 mW/cm2, as shown
in Figure 7. When intralipids were added (5 wt%), the
photopolymerization time t95 was non-significantly reduced to
7min+ 38 s± 1min 16 s (p = 0.6318). In addition, the G′ plateau
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FIGURE 3 | Schematic illustration of the in vitro setup to evaluate the feasibility of the implantation. The peristaltic pump induced a pulsatile flow of 220 ml/min at
1 Hz. The height of the liquid column ensured a constant pressure of 12 kPa to the system. A parallel bifurcation channel, representing collateral shunting or outflow
in the head and neck during balloon inflation at the aneurysm neck was added to dissipate over-pressurization and avoid bursting or displacing the balloon when
inflated. The input represents access to the internal carotid artery through which a 9 French introducer sheath and an 8 French guiding catheter were placed,
followed by navigation of the light-conducting microcatheter and balloon to the aneurysm site.
FIGURE 4 | (A) Illumination module to which the optical fibers are connected. (B) Schematic of the light-conducting microcatheter from different views (i) overall, (ii)
side, and (iii) front view.
was measured to be 59.48 ± 4.70 kPa and 51.43 ± 7.53 kPa,
without and with 5% intralipids respectively (p = 0.1914).
In vitro Proof-of-Concept of
Implementation
The light-conducting microcatheter (Figure 5B) was subjectively
stiffer than the standard clinical microcatheter, due to the heat
shrink tube wrapping around the glass optical fibers along the
outer surface but this did not affect the navigation inside the
silicone model and also ensured mechanical protection of the
fibers. After positioning the balloon at the aneurysm neck in
the parent vessel, the distal tip of the microcatheter (distal
radiopaque marker) was placed inside the aneurysm within a few
minutes, as shown in Figure 8A. Figure 9 shows the optical fiber
illumination in situ.
Fluoroscopically controlled balloon inflation was easily
achieved (Figure 8B) followed by contrast agent injection to
rinse the blood substitute volume out of the aneurysm cavity.
Subsequently, the hydrogel precursor was injected through the
microcatheter with a similar resistance to a regular contrast
injection, according to the experienced neuro-interventionalist
performing the injection (PJM) and depicted in Figure 8C. The
aneurysm was considered to be completely filled by the hydrogel
precursor after all the contrast agent was replaced under blank
map fluoroscopy (initially no contrast visible followed by negative
contrast [white aspect] during contrast agent removal and finally
positive contrast [black aspect] as the precursor filled the cavity).
Direct visual inspection was used to confirm the complete filling
of the aneurysm. A small residual inflow from the parent artery
in the aneurysm was observed, despite maximal balloon inflation
at the junction between the balloon and the microcatheter. This
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 6 April 2020 | Volume 8 | Article 261
Poupart et al. Photopolymerizable Hydrogels for Intracranial Aneurysms
FIGURE 5 | FT-IR spectrum of PEGDMA polymer.
FIGURE 6 | (A) Dynamic viscosities for Accupaque350, water, and hydrogel precursor by rheology measurements (n = 3). (B) Radiography snapshot of (i) a deflated
balloon with its two proximal and distal radiopaque markers, (ii) pure Accupaque350, (iii) hydrogel precursor, (iv) polymerized hydrogel immediately after
photopolymerization and (v) polymerized hydrogel after 36 h-immersion in PBS.
inflow was probably due to the rigidity and low compliance of the
silicone model, a feature not generally observed in physiological
conditions, unless the balloon leaks or is not sufficiently inflated.
To match physiological conditions, the pump parameters were
adapted until flow was almost stopped (25 ml/min) while
the balloon was inflated. Despite this corrective measure, we
observed some leakage of the precursor in the parent vessel
and ophthalmic artery. The optical fibers connected to the
illumination module were then used to illuminate the aneurysm
with 25 mW/cm2 of light at 405 nm. After 8 min of continuous
in situ illumination of the hydrogel precursor (in a darkened
room with no ambient light), the microcatheter was removed
under fluoroscopy without fragmenting the hydrogel, suggesting
minimal adhesion to the microcatheter.
Figure 10 shows the progressive deflation and removal of
the balloon and solidified photopolymerized hydrogel in situ in
almost physiological hemodynamic conditions.
Cell Viability of Precursor and Hydrogel
As displayed in Figure 11A, the hydrogel precursor was diluted
to different concentrations, ranging from 10 to 0.1%. The
viability assay showed that a concentration of 10 vol% lead to
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FIGURE 7 | Storage modulus G’ evolution during the photopolymerization of
PEGDMA hydrogels with and without intralipids (n = 3).
49.65 ± 3.77% cell death after 3 days of contact, which was non-
significantly different after 1 week of contact. For concentration
lower than 5 vol%, the viability increased after 3 days and
a decrease was noticed after 1 week. However, this viability
decrease was still acceptable, accordingly to ISO 10993-4 which
requires a viability higher that 70%. Similarly, incubation of
HUVEC cells with pure precursor during 10 min (representing
the worst-case scenario with the most toxic concentration of
leaked precursor in the parent artery during balloon inflation and
in situ illumination) did not negatively impact viability, as shown
for the serial dilutions at different speeds. This result suggests that
longer contact time of low concentration hydrogel (<5 vol%) is
highly unlikely to be toxic under realistic in vivo conditions.
Beyond a week of contact with HUVEC, polymerized
hydrogels, directly after photopolymerization and after 1 day
of swelling in PBS, exhibited a viability of 89.78 ± 14.65 and
97.65 ± 8.33, respectively, as shown in Figure 11B. Therefore,
the hydrogel fulfilled the ISO 10993-4 requirements, implying no
toxic effect of the hydrogel on HUVEC.
Platelet Aggregation
Platelet aggregation was measured for different concentrations
of precursor, ranging from 0.1 to 10 vol% and compared with
Tyrode buffer as negative control and Collagen I and PPP, as
positive controls, as shown in Figure 12. The assay indicated
the aggregation of the precursor at different concentrations are
not significantly different from the negative control, where the
platelets did not aggregate. The negative values of aggregation
might be explained by the sampling variations (n = 3 donors,
3 samples/donor). Therefore, for concentration lower than 10
vol%, the precursor seems not to induce any platelet aggregation.
DISCUSSION
The present study is, to the best of our knowledge, the first
to demonstrate the feasibility of in situ implementation using
the same microcatheters as in clinical practice, as well as
photoactivation and polymerization of hydrogels to treat IAs.
A major strength of our work is the development of a low
viscosity precursor injectable through the same microcatheters
as those used for coiling, i.e., with an inner diameter of 430 µm
(1.7 French outer diameter). In comparison, the injectability
of precursors until now was feasible through 4–6 French-
catheters (1.33–2 mm outer diameter) (Takao et al., 2006;
Ishikawa et al., 2012; Bearat et al., 2013; Weng et al., 2013;
Avery et al., 2016; Shi et al., 2016). A pH-sensitive hydrogel was
injected through a 2 French-catheter (490 µm inner diameter)
(Nguyen et al., 2016), but so far we found no evidence of a
similar or alternative hydrogel injectable through a 1.7 French-
microcatheter or smaller. The viscosity in our hydrogel precursor
was most affected by the iodinated contrast agent rather than the
PEGDMA monomer. By using other clinically approved but less
viscous contrast agents, it might be possible to further reduce
resistance to injection in small microcatheters. Accupaque300
(GE Healthcare) or Visipaque270 (Nycomed), notably, have
a viscosity at 20◦C of 11.6 and 11.3 mPa.s, respectively,
corresponding to a drop of almost 40%.
Radiopacity of the hydrogel is indispensable for aneurysm
embolization. In this study, the addition of 50 wt% iodinated
contrast agent in the composition allowed both precursor and
FIGURE 8 | Subtracted (A) and (B–D) unsubtracted fluoroscopic images showing (A) contrast agent injection into the model to visualize the dimensions of the
parent artery, aneurysm and ophthalmic artery; (B) guide catheter, inflated balloon (slightly prolapsing in the aneurysm) and light-conducting microcatheter in place;
(C) injection of the hydrogel precursor through the microcatheter and (D) polymerized hydrogel after 8 min of 405 nm illumination and removal of the light-conducting
microcatheter.
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FIGURE 9 | Optical fiber in situ illumination through the microcatheter in the aneurysm.
FIGURE 10 | Unsubtracted fluoroscopic images of (A) deflation and (B–D) progressive removal of the balloon. Note that radiopacity is reduced compared to (A) due
to slow residual inflow of blood substitute during polymerization. Recycled contrast agent after re-establishment of blood flow throughout the model is visible on
(C,D).
FIGURE 11 | (A) HUVEC viability of different concentrations and dilutions of hydrogel precursors (n = 4). (B) HUVEC viability after 1 week of direct contact with
PEGDMA hydrogels either immediately after polymerization or after 1 day of swelling in PBS following polymerization (n = 3).
hydrogel to be radiopaque. It has been shown that hydrogel
radiopacity remains acceptable under fluoroscopy with 20–25
wt% iodinated contrast medium (Takao et al., 2006; Barnett et al.,
2009; Fatimi et al., 2011; Nguyen et al., 2016). In other words,
we could further decrease the radiopaque agent content in our
formulation and hence viscosity, without significantly altering
the fluoroscopic visibility of the liquid precursor. Radiopaque
nanoparticles might also improve injectability to an even greater
extent (Tian et al., 2018) and allow a higher percentage of
polymer, thereby potentially shortening the photosolidification
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FIGURE 12 | Platelet aggregation of different concentrations of hydrogel
precursors (n = 3).
process to a minute or less. It is known that iodinated contrast
agents are subject to leak to the surrounding environment (Lei
et al., 2016), as it was demonstrated for our hydrogel over
the following days due to the immersion process (Figure 6B).
In contrast to coiling or clipping (Hänsel et al., 2018) or
use of EVOH agents (Saatci et al., 2003) where artifacts are
usually observed after treatment, the fast leakage of iodine has
the potential to increase the quality of follow up imaging on
Computed Tomography (CT) or Magnetic Resonance Imaging
(MRI). The intra-aneurysmal content might become easier to
evaluate in terms of recurrence without the need for follow up
digital subtraction angiography (DSA), which requires arterial
catheterization and still carries a small but relevant risk of
iatrogenic ischemic stroke (Connors et al., 2005).
A further novelty of our approach is the use of a new type of
water-soluble photoinitiator that is activated by visible light and
allows the hydrogel to completely photopolymerize within 8 min.
For biomedical applications, Irgacure2959 remains the most
widely used water-soluble photoinitiator. Its major drawbacks are
longer polymerization times, approximatively 25 min for 6 kDa
PEGDMA hydrogels (Khoushabi et al., 2015), and the need for
ultraviolet light, which may damage the DNA of the encapsulated
cells or host tissues (Sinha and Häder, 2002; Fedorovich et al.,
2009). Other water-soluble photoinitiators sensitive to visible
light, such as lithium phenyl2,4,6-trimethylbenzoylphosphinate
(LAP), 2,2′-azobis[2- methyl-n-(2-hydroxyethyl)propionamide]
(VA-086) or eosin, used in tissue engineering (Wang Z. et al.,
2018) might also be of interest. Intralipids were added to the
composition for their intrinsic scattering properties. The impact
of these particles were not significantly noticed in this test.
However, it should be noted that the photorheology bench test
we performed was on thin samples (300 µm thickness) under
homogeneous illumination using 405 nm light over the whole
surface of the sample. The effect of light scattering particles
becomes significant when the sample is polymerized in depth and
when light is not homogeneously distributed (Schmocker et al.,
2014). Therefore, the small decrease of photopolymerization
time might be explained by the scattering particles which help
illuminate the sample in a homogenous manner. Therefore,
we hypothesized that adding intralipids would enhance light
distribution and photoactivation in more complex environments
such as a human brain aneurysm, although this did not
affect photopolymerization time in the test. In addition, the
acceleration of the curing could also explain the reduction of the
G’modulus, since it might cause porosity in the hydrogel network
and therefore lower mechanical properties.
A handful of studies have focused on the embolization of
IAs using chemical and physical cross-linked hydrogels (Takao
et al., 2006; Bearat et al., 2013; Weng et al., 2013), usually
limited by premature gelation or later dilution. Takao et al.
(2006) managed to embolize a wide-necked lateral wall aneurysm
using a thermo-reversible hydrogel but with the drawback of
solidifying into themicrocatheter during delivery, rendering their
applicability in humans unlikely. Consequently, a further benefit
of the photopolymerizable hydrogel we have developed is the
controllability of its solidification. Indeed, photoactivation can
be triggered precisely by the operator by selectively switching
the illumination module on. Moreover, it is theoretically possible
to implement a feedback loop coupled to sound to monitor the
solidification process by using light of a different wavelength
through the same optical fiber (Schmocker et al., 2015).
The relevance of silicone aneurysmsmodels for in vitro studies
to test new devices, such as coils, stents or embolic agents
was previously confirmed in multiple studies (Paramasivam
et al., 2014). Similar in vitro pulsatile flow setups for aneurysm
embolization (ranging from 100 to 300 ml/min) were developed
in a few studies (Ishikawa et al., 2012; Bearat et al., 2013).
A patient-specific carotid ophthalmic aneurysm silicone model
enabled us to assess real-life navigation of the light-conducting
microcatheter prototype, despite limitations such as the absence
of endothelial lining or natural elastic and lubricity conditions.
Nonetheless, microcatheterization of the aneurysm and visible
light emission in situ was feasible in physiologically approaching
hemodynamic conditions. Although a similar optical system was
developed by Barnett et al. (2009) using a commercially available
Excimer laser catheter sheath attached to a UV connection box
for aortic and saccular aneurysm treatment, its minimal diameter
of 0.9 mm limits its use for IAs, not to mention the danger of UV
light previously discussed. Pushing an optical fiber through the
inner lumen of a 430 µm microcatheter proved to be extremely
time consuming in our experience and almost impossible in case
of curvy or loopy anatomy. The risk of breaking the optic fiber
was high, as well as the risk of vessel wall perforation related to
the absence of radiopaquemarker at the distal tip. The heat shrink
tube ensuredmechanical protection of the fibers but increased the
bulkiness of the microcatheter. Braiding the optical fibers directly
in the plastic wall of the microcatheter would be an elegant way
to ensure mechanical protection without increasing the overall
diameter.
A limitation of our implementation system is that it is difficult
to rinse the blood out of the aneurysm entirely with the precursor
and to keep the latter trapped inside to fill the whole volume
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before photoactivation. It is also challenging to avoid blood
contamination from residual inflow during balloon inflation that
could hinder the polymerization process. We tried to solve this
issue by inflating the balloon in a submaximal fashion so that
the precursor could be injected at a rate higher than the residual
blood inflow until it leaked out into the parent artery, at which
point the balloon was inflated to obtain complete sealing of the
neck. It remains to be shown whether this technical feature is
applicable in a real clinical situation.
Since leakage into the parent artery is virtually inevitable
and should be expected, biocompatibility of the liquid precursor
is essential. Compared to precipitating EVOH embolic agents
containing potentially toxic DMSO (Santos et al., 2003) or to
rapidly polymerizing substances such acrylic glues (Suh et al.,
2003), the photoactive hydrogel precursor we have developed
consists of clinically approved solvents only, can be selectively
polymerized on demand with visible light and demonstrates no
toxicity for endothelial cells in both its liquid and solid states.
Contrary to chemical, temperature- or pH-sensitive hydrogel
precursors that have a high risk of polymerizing in the parent
artery in case of leakage, our preliminary tests indicate that our
light-sensitive precursor should be harmless if injected into the
blood stream and should not induce any platelet aggregation.
Nevertheless, cytotoxicity and thrombogenicity have to be further
studied in vitro and in vivo, which we will test systemically in
rats before moving to in situ photopolymerization in an elastase-
aneurysm model in rabbits (Brinjikji et al., 2016).
CONCLUSION
Our study reveals the potential of photopolymerizable hydrogels
for IA treatment. The developed hydrogel was shown to have a
low viscosity enabling injection through 430 µmmicrocatheters,
to solidify within less than 10 min using visible light and to be
radiopaque under fluoroscopy. The proof-of-concept of in situ
implementation of the hydrogel was validated in a realistic flow
model of a human brain aneurysm replica, using a customized
light-conducting microcatheter. In addition, the precursor and
hydrogel were proved to be biocompatible.
While this new type of liquid embolic agent has the potential
to overcome the limitations of current endovascular implants,
further biomechanical characterization, as well as in vivo studies
are needed to confirm these preliminary results and to evaluate
other key features, such as clinical safety, thrombogenicity, tissue
adherence, endothelialization and long-term durability.
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